Ovarian cancer
Do you want to receive a message when there is new research about Ovarian cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication there is one sentence explaining what was investigated — and you will receive a message as soon as there is new research about Ovarian cancer. View what Premium costs.
Publications and studies (2862)
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Clinical case: successful birth as a result of the transfer of an embryo at the blastocyst stage from an oocyte obtained from a tumoral ovary using the OTO-IVM method. (2026/07/17) ♡
- Immunofluorescence-Based Assay for Detection of Nuclear RAD51 Foci as a Marker of Homologous Recombination Repair in Ovarian Cancer Cells. (2026/07/17) ♡
- Molecular Characterization of Ovarian Metastases from Colorectal Cancer Using Circulating Tumor DNA Analysis. (2026/07/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe delayed diaphragmatic hernia with total gastric migration after cytoreductive surgery, a rare complication: A case report. (2026/07/15) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. [Impact of the Mediterranean diet on the prevention, prognosis, and clinical management of gynecological and breast cancers: a systematic review]. (2026/07/14) ♡
- What Does It Really Mean to Support Exclusive Breastfeeding in Southern Africa? It's Time to Shift the Paradigm. (2026/07/12) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Response to Correspondence of Cheng W. et al. on "Decoding BRCA1 and BRCA2 mutations in high-grade serous ovarian cancer: impact of location and type of mutation on prognosis and PARP inhibitor treatment" by Momi M. et al. (2026/07/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Best original research presented at the 27th European Congress on Gynaecological Oncology: best of ESGO 2026. (2026/07/11) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Personalized circulating tumor DNA-based minimal residual disease assessment for optimizing interval debulking surgery timing in advanced ovarian cancer: toward precision surgical oncology. (2026/07/11) ♡
- Cuproptosis-mediated stemness inhibition by a self-assembled herbal nanoplatform overcomes chemoresistance in ovarian cancer. (2026/07/09) ♡
- Adherence to a diet with higher protein quality significantly reduces the risk of lung cancer: results from a population-based prospective study. (2026/07/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multidisciplinary management of advanced ovarian cancer in Spain: expert recommendations for achieving maximum survival and improving patient care. (2026/07/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. DASH, Mediterranean, and Plant-Based Diets and Cancer Risk in Women: A Narrative Review Based on Diet Quality Indices. (2026/07/03) ♡
- Longitudinal kinetics of human epididymis protein 4 in recurrent advanced ovarian carcinoma treated with platinum-based chemotherapy: mathematical modeling and prognostic implications. (2026/07/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Global Perspective on Fertility-Sparing Surgical Oncology in Gynaecology: A Narrative Literature Review. (2026/07/03) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study the Changing Trends of Age at Diagnosis of Breast Carcinoma in Correlation with Polycystic Ovarian Syndrome, Obesity, and Nutritional Status. (2026/07/01) ♡
- Interval versus primary cytoreductive surgery in BRCA-mutated advanced-stage ovarian/peritoneal/tubal carcinoma. (2026/07/01) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II). (2026/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of The Surgical Pathologist in the Recognition of Hereditary Gynecologic Cancer. (2026/07/01) ♡
- Fertility preservation trends, perspectives, and reflections in gender diverse adults across the life course. (2026/07/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Multimodal prehabilitation in patients with advanced ovarian cancer. (2026/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Defining surgical fitness in advanced ovarian cancer: a critical review of predictors, algorithms, and pre-habilitation. (2026/07/01) ♡
- Metabolomic signature of ultra-processed foods and cardiovascular morbidity and mortality. (2026/07/01) ♡
- Sedentary behaviour and cancer risk: a World Cancer Research Fund International Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis. (2026/06/29) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. The Effects of Time-Restricted Eating in Women with Polyendocrine Metabolic Ovarian Syndrome: A Systematic Review and Meta-Analysis. (2026/06/26) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Correspondence on "Reconsidering the control arm in hyperthermic intra-peritoneal chemotherapy trials for epithelial ovarian cancer: are we comparing equivalent chemotherapy exposure?" by Poonyakanok et al. (2026/06/26) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Role of individualized intervention(s) on quality of life and adherence to adjuvant endocrine therapy in premenopausal women with early-stage breast cancer: MyCHOICE study. (2026/06/26) ♡
- Pre-operative Nutritional Risk Screening 2002-based nomograms for predicting post-operative complications after cytoreductive surgery for ovarian cancer: a multi-center retrospective cohort study. (2026/06/26) ♡
- Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors. (2026/06/25) ♡
- Correction: Benna-Doyle et al. Investigating the Prognostic Value of Pretreatment Body Composition in Women with Ovarian Cancer: Impact on Clinical Outcomes. Cancers 2026, 18, 1478. (2026/06/25) ♡
- Untargeted metabolomics of cervicovaginal fluid in patients with ovarian cancer. (2026/06/22) ♡
- Somatic BRCA1 and BRCA2 detection in homologous recombination deficiency testing: concordance of four sequencing workflows with the Myriad myChoice companion diagnostic. (2026/06/20) ♡
- Utility of preoperative outcomes of nutritional evaluation in patients with newly diagnosed ovarian cancer. (2026/06/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Potential Role of Vitamin D in BRCA1 Pathogenic Variant Carriers: A Narrative Review. (2026/06/19) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Successful Multimodal Treatment for High-Grade Serous Ovarian Cancer with BRCA2 Heterozygous Deletion with Multiple Recurrences: A Case Report. (2026/06/19) ♡
- Postoperative Inflammatory and Nutritional Biomarkers for Predicting Anastomotic Leakage After Ovarian Cancer Surgery: A Multicenter Study. (2026/06/17) ♡
- Baozhu Granule as a Novel Treatment Strategy for Diminished Ovarian Reserve: A Prospective Clinical Trial. (2026/06/17) ♡
- Long-term outdoor air pollution and risk of ovarian and endometrial cancers in a large prospective cohort. (2026/06/15) ♡
- The Impact of Malnutrition on Post-Operative Complications in Patients with Ovarian Cancer: A NSQIP Study. (2026/06/15) ♡
- Yiyi Fuzi Baijiang powder exerts anti-ovarian cancer effects via the JNK/c-Jun signaling pathway and modulation of the tumor inflammatory microenvironment. (2026/06/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in ferroptosis research in ovarian cancer: molecular mechanisms and therapeutic perspectives. (2026/06/15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of the TiaoShenZhiAi Regimen for Patients With Ovarian Cancer Experiencing a Psychoneurological Symptom Cluster: Protocol for a Multicenter, Double-Blind, Randomized Controlled Trial. (2026/06/12) ♡
- The healthy eating index 2020 and colorectal cancer risk: a prospective study based on the PLCO cohort. (2026/06/11) ♡
- Intermittent fasting synergizes with GCN5 inhibition to suppress RBM5-AS1/GCN5/PGC-1α-driven Warburg metabolism in ovarian cancer. (2026/06/10) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Risk factors associated with postoperative lymphocele in patients with gynecological malignant tumors: a systematic review and meta-analysis. (2026/06/10) ♡
- Associations of novel adiposity indices with gynecological cancer risk among adult women: Evidence from NHANES 2011 to 2018. (2026/06/05) ♡
- Deciphering the Pleiotropic Role of ARID1a and RIF1 in Endometrioid Ovarian Cancer. (2026/06/04) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Metabolomic profiling of genotype-derived ABO blood group, secretor status, and Lewis antigens and association with pancreatic ductal adenocarcinoma risk. (2026/06/03) ♡
- Expression of adenosine A1, A2A, A2B, and A3 receptors in ovarian cancer: their clinical potential in diagnosis and prognosis. (2026/06/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Obesity as a Systems-Level Driver of Cancer: Mechanisms and Nutritional Reprogramming. (2026/06/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.